Skip to content

Opening book details…

Can I read Alternative- and focal therapy trends for prostate cancer: a total population analysis of in-patient treatments in Germany from 2006 to 2019 on EtoBox?

Alternative- and focal therapy trends for prostate cancer: a total population analysis of in-patient treatments in Germany from 2006 to 2019 by Luka Flegar; Aristeidis Zacharis; Cem Aksoy; Hendrik Heers; Marcus Derigs; Nicole Eisenmenger; Angelika Borkowetz; Christer Groeben; Johannes Huber is a Medicine article available to read on EtoBox.

What is Alternative- and focal therapy trends for prostate cancer: a total population analysis of in-patient treatments in Germany from 2006 to 2019 about?

## Purpose Focal therapy (FT) offers an alternative approach for prostate cancer (PCa) treatment in selected patients. However, little is known on its actual establishment in health care reality. ## Patients and methods We defined FT as high-intensity focused ultrasound (HIFU), hyperthermia ablation, cryotherapy, transurethral ultrasound ablation (TULSA) or vascular-targeted photodynamic therapy (VTP) TOOKAD^®^. We analyzed the nationwide German hospital billing database for a PCa diagnosis in combination with FT. For analyses on the hospital level, we used the reimbursement.INFO tool based on hospitals’ quality reports. The study period was 2006 to 2019. ## Results We identified 23,677 cases of FT from 2006 to 2019. Considering all PCa cases with surgery, radiotherapy or FT, the share of FT was stable at 4%. The annual caseload of FT increased to a maximum of 2653 cases in 2008 (__p__ < 0.001) and then decreased to 1182 cases in 2014 (__p__ 20 FT procedures. In 2019, 16% (58/368) of urological departments performed FT and 7 departments reached > 20 FT. In 2019, 25 urological departments offered FT other than HIFU: 5 centers hyperthermia ablation, 11 centers VTP TOOKAD^®^, 3 cent

Who reads Alternative- and focal therapy trends for prostate cancer: a total population analysis of in-patient treatments in Germany from 2006 to 2019?

It is typically read by researchers, students, and practitioners in Medicine.

Author
Luka Flegar; Aristeidis Zacharis; Cem Aksoy; Hendrik Heers; Marcus Derigs; Nicole Eisenmenger; Angelika Borkowetz; Christer Groeben; Johannes Huber
Publisher
Springer Science and Business Media LLC
Published
2022
Language
EN
Field
Medicine (Health Sciences)

More by Luka Flegar; Aristeidis Zacharis; Cem Aksoy; Hendrik Heers; Marcus Derigs; Nicole Eisenmenger; Angelika Borkowetz; Christer Groeben; Johannes Huber

Browse all works by Luka Flegar; Aristeidis Zacharis; Cem Aksoy; Hendrik Heers; Marcus Derigs; Nicole Eisenmenger; Angelika Borkowetz; Christer Groeben; Johannes Huber